Drug Shortage Report for POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Report ID | 43635 |
Drug Identification Number | 00037869 |
Brand name | POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP |
Common or Proper name | POTASSIUM CHLORIDE |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE |
Strength(s) | 149MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 25 X 20mL PVL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-08-06 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-06-06 |
Shortage status | Avoided shortage |
Updated date | 2018-06-07 |
Company comments | 10mL presentatation remains available. Preventative allocation measures are in place for both. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-06-07 | French | Compare |
v9 | 2018-06-07 | English | Compare |
v8 | 2018-05-30 | French | Compare |
v7 | 2018-05-30 | English | Compare |
v6 | 2018-05-30 | English | Compare |
v5 | 2018-05-30 | French | Compare |
v4 | 2018-05-30 | English | Compare |
v3 | 2018-03-21 | English | Compare |
v2 | 2018-03-21 | French | Compare |
v1 | 2018-03-21 | English | Compare |
Showing 1 to 10 of 10